Pictet Asset Management Holding SA »

Theravance Biopharma shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 2.0M 8.99

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
BlackRock
Irenic Capital Management
Vanguard Group
Pictet Asset Management Holding SA
Newtyn Management
Oasis Management
Park West Asset Management
Geode Capital Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Bank of America Corporation
Northern Trust
Morgan Stanley

View all funds holding Theravance Biopharma